Abstract
Animal cells from endocrine glands have potential applications in bioprocessing, for the production of hormones, enzymes, possibly also recombinant proteins, and in tissue engineering, for the development of immunoisolated, implantable devices for long-term treatment of endocrine disorders. Immunoisolation can be achieved by surrounding cells with a biocompatible polymer which allows diffusion of nutrients and metabolites, including hormones, but excludes higher molecular weight antibodies and cytotoxic cells. Primary hormone-secreting cells cannot be effectively amplified in culture, so the large-scale application of implantable systems based on such cells is limited by cell availability. In this study, we conducted an initial assessment of the feasibility of using transformed, continuous cell lines in immunoisolated devices. The model system employed consisted of mouse pituitary tumor AtT-20 cells which secrete recombinant proinsulin and an insulin-like peptide and exhibit a high growth potential. Cells were cultivated as spheroids in spinner flasks and entrapped as such in alginate/polylysine/alginate beads. Free and entrapped spheroids were propagated in fed-batch, suspension cultures. Entrapment did not significantly affect spheroid metabolism or basal secretion. Entrapped spheroids did not increase in size or number and maintained roughly constant metabolic and basal secretory activities over a 15-day period. Free spheroids in suspension increased in size during the sami period, but also maintained constant metabolism and basal secretion, apparently because of a concomitant increase in hypoxic and/or necrotic cells. The potential of using continuous cell lines in the development of bioartificial endocrine organs is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burgess TL and Kelly RB (1987) Constitutive and regulated secretion of proteins. Ann. Rev. Cell Biol. 3: 243–293.
Dale BE and Gillies RJ (1991) Nuclear magnetic resonance spectroscopy of dense cell populations for metabolic studies and bioreactor engineering: a synergistic partnership. In: Animal Cell Bioreactors, pp. 107–118 (Ho CS and Wang DIC, Eds.), Boston: Butterworth-Heinemann.
Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D and Baekkeskov S (1988) Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. USA 85: 9037–9041.
Fan M-Y, Lum Z-P, Fu X-W, Levesque L, Tai IT and Sun AM (1990) Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 39: 519–522.
Freyer JP (1988) Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res. 48: 2432–2439.
Freyer JP and Sutherland RM (1986) Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply. Cancer Res. 46: 3504–3512.
Galletti PM and Aebischer P (1988) Bioartificial organs, In: Tissue Engineering: Proceedings of a Workshop Held at Granlibakken, Lake Tahoe, California, February 26–29, pp. 211–216 (Skalak R and Fox CF, Eds.) New York: Liss.
Goetghebeur S and Hu W-S (1991) Cultivation of anchorage-dependent animal cells in microsphere-induced aggregate culture. Appl. Microbiol. Biotechnol. 34: 735–741.
Goosen MFA (1987) Insulin delivery systems and the encapsulation of cells for medical and industrial use. CRC Critical Reviews in Biocompatibility 3:1–24.
Gotfredsen C, Stewart MG, O'Shea GM, Vose JR, Horn T and Moody AJ (1990) The fate of transplanted encapsulated islets in spontaneously diabetic BB/Wor rats. Diabetes Res. 15: 157–163.
Grampp GE, Sambanis A and Stephanopoulos GN (1992) Use of regulated secretion in protein production from animal cells: an overview. Advances Biochem. Engin./Biotechnol. 46: 35–62.
Hamaguchi K, Tatsumoto N, Fujii S, Okeda T, Nakamura M, Yamaguchi K, Fujimori O and Takaki R (1986) Microencapsulation of pancreatic islets. A technique and its application to culture transplantation. Diabetes Res. Clin. Practice 2: 337–345.
Hicks BA, Stein R, Efrat S, Grant S, Hanahan D and Demetriou AA (1991) Transplantation of β cells from transgenic mice into nude athymic diabetic rats restores glucose regulation. Diabetes Res. Clin. Practice 14: 157–164.
Hu W-S and Peshwa MV (1991) Animal cell bioreactors recent advances and challenges to scale up. Can. J. Chem. Eng. 69: 409–420.
Hughes SD, Johnson JH, Quaade C and Newgard CB (1992) Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc. Natl. Acad. Sci. USA 89: 688–692.
Kelly RB (1985) Pathways of protein secretion in eucaryotes. Science 230: 25–32.
King GA, Daugulis AJ, Faulkner P and Goosen MFA (1987) Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotechnol. Progress 3: 231–240.
Lee GM, Chuck AS and Palsson BO (1993) Cell culture conditions determine the enhancement of specific monoclonal antibody productivity of calcium alginate-entrapped S3H5/gamma2bA2 hybridoma cells. Biotechnol. Bioeng. 41: 330–340.
Lim F and Sun AM (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908–910.
Mains RE, Cullen EI, May V and Eipper BA (1987) The role of secretory granules in peptide biosynthesis. Ann. NY Acad. Sd. 493: 278–291.
Moore H-PH (1986) Factors controlling packaging of peptide hormones into secretory granules. Ann. NY Acad. Sci. 493: 50–61.
Moore H-PH and Kelly RB (1985) Secretory protein targeting in a pituitary cell line: differential transport of foreign secretory proteins to distinct secretory pathways. J. Cell Biol. 101: 1773–1781.
Moore H-PH, Walker MD, Lee F and Kelly RB (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35: 531–538.
Papas KK (1992) Characterization of the metabolic and secretory behavior of suspended free and entrapped AtT-20 spheroids in fed-batch and perfusion cultures. MS thesis, Georgia Institute of Technology, Atlanta GA.
Papas KK and Sambanis A, in preparation.
Sambanis A, Stephanopoulos G, Sinskey AJ and Lodish HF (1990a) Use of regulated secretion in protein production from animal cells: an evaluation with the AtT-20 model cell line. Biotechnol. Bioeng. 35: 771–780.
Sambanis A, Stephanopoulos G and Lodish HF (1990b) Multiple episodes of induced secretion of human growth hormone from recombinant AtT-20 cells. Cytotechnology 4: 111–119.
Soon-Shiong P and Lanza RP (1990) Pancreas and islet-cell transplantation. Postgraduate Medicine 87: 133–140.
Sun AM, Parisius W, Healy GM, Vacek I and Macmorine H (1977) The use in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas). Diabetes 26: 1136–1139.
Sun AM, Parisius W, Macmorine H, Sefton MV and Stone R (1980) An artificial pancreas containing cultured islets of Langerhans. Artif. Organs 4: 275–278.
Sun AM and O'Shea GM (1985) Microencapsulation of living cells—a long-term delivery system. J. Controlled Release 2: 137–141.
Sun AM (1988) Microencapsulation of pancreatic islet cells: a bioartificial endocrine pancreas. Methods Enzymol. 137: 575–580.
Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177–184.
Thomas JN (1986) Nutrients, oxygen and pH. In: Mammalian Cell Technology, pp 109–130 (Thilly WG, Ed.), Stoneham, MA: Butterworth Publishers.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Papas, K.K., Constantinidis, I. & Sambanis, A. Cultivation of recombinant, insulin-secreting AtT-20 cells as free and entrapped spheroids. Cytotechnology 13, 1–12 (1993). https://doi.org/10.1007/BF00749970
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00749970